Preferred Label : darunavir ethanolate;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

CAS number : 618109-00-5; 33O78XF0BW;

Is substance : O;

UNII : 33O78XF0BW;

InChIKey : QWSHKNICRJHQCY-VBTXLZOXSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2876133/fr/prezista
2018
false
false
false
France
darunavir ethanolate
darunavir
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
prezista
Darunavir

---
http://www.has-sante.fr/portail/jcms/c_2621282/fr/prezista
2016
false
France
French
Darunavir
Darunavir
human immunodeficiency virus i infection
ritonavir
evaluation of the transparency committee
administration, oral
darunavir ethanolate
drug therapy, combination
HIV-1
hiv infections
hiv protease inhibitors
hiv protease inhibitors
adult
child
adolescent
treatment outcome
clinical trials, phase ii as topic
insurance, health, reimbursement
sulfonamides
sulfonamides
darunavir ethanolate

---
http://www.has-sante.fr/portail/jcms/c_1747988/fr/prezista-darunavir-inhibiteur-de-protease
2014
false
France
French
evaluation of the transparency committee
guidelines for drug use
Darunavir
Darunavir
insurance, health, reimbursement
administration, oral
hiv infections
adolescent
HIV-1
darunavir ethanolate
darunavir
treatment outcome
darunavir ethanolate
hiv protease inhibitors
hiv protease inhibitors
drug therapy, combination

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=64478874
2013
summary of product characteristics
suspensions
darunavir ethanolate

---
http://www.meddispar.fr/Medicaments/PREZISTA-100-B-1/(type)/letter/(value)/P/(cip)/3400926704957
2013
false
France
French
Darunavir
drug information
pharmaceutical solutions
administration, oral
darunavir ethanolate
darunavir
drug prescriptions
legislation, drug

---
http://www.meddispar.fr/Medicaments/PREZISTA-800-B-30/(type)/letter/(value)/P/(cip)/3400926788704
2013
false
France
French
Darunavir
drug information
administration, oral
darunavir ethanolate
darunavir
drug prescriptions
legislation, drug

---
http://www.has-sante.fr/portail/jcms/c_1525564/prezista
2013
false
France
French
Darunavir
Darunavir
evaluation of the transparency committee
administration, oral
darunavir ethanolate
drug therapy, combination
HIV-1
hiv infections
hiv protease inhibitors
hiv protease inhibitors
adult
child
adolescent
treatment outcome
clinical trials, phase ii as topic
insurance, health, reimbursement
darunavir ethanolate

---
https://www.ema.europa.eu/medicines/human/EPAR/Prezista
2012
false
United Kingdom
English
French
syndication feed
Darunavir
Darunavir
hiv protease inhibitors
hiv infections
hiv protease inhibitors
drug evaluation
treatment outcome
drug approval
drug labeling
tablets
administration, oral
acquired immunodeficiency syndrome
HIV-1
drug therapy, combination
drug interactions
pregnancy
breast feeding
darunavir
darunavir ethanolate
drug evaluation
package leaflet
summary of product characteristics

---
http://www.has-sante.fr/portail/jcms/c_1352584/prezista
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12454_PREZISTA%20Gamme_RI_P1_CT%2012454.pdf
http://www.has-sante.fr/portail/jcms/c_900460/prezista
http://www.has-sante.fr/portail/jcms/c_1060966/prezista-ct-7149-7150-version-anglaise
2012
false
France
French
English
Darunavir
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
darunavir ethanolate
darunavir
HIV-1
hiv infections
adult
adolescent
child
hiv protease inhibitors
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1172428/prezista
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/prezista_14-12-2011_avis_ct11428.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/prezista_ct_11428.pdf
2011
false
France
French
English
evaluation of the transparency committee
Darunavir
Darunavir
darunavir
administration, oral
insurance, health, reimbursement
hiv protease inhibitors
HIV-1
adult
hiv infections
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
darunavir ethanolate
darunavir ethanolate
hiv protease inhibitors

---
http://www.meddispar.fr/medicaments/3959513
2010
false
France
French
Darunavir
darunavir
tablets
administration, oral
legislation, drug
drug prescriptions
darunavir ethanolate
drug information

---
http://www.meddispar.fr/medicaments/3959536
2010
false
France
French
Darunavir
tablets
administration, oral
legislation, drug
drug prescriptions
darunavir
darunavir ethanolate
drug information

---
http://www.has-sante.fr/portail/jcms/c_929080/prezista-darunavir-inhibiteur-de-protease
2010
false
France
French
Darunavir
hiv protease inhibitors
darunavir
child
drug therapy, combination
HIV-1
hiv infections
adolescent
acquired immunodeficiency syndrome
treatment outcome
darunavir ethanolate
evaluation of the transparency committee

---
http://www.meddispar.fr/index.php/medicaments/3931408
2009
false
France
French
Darunavir
darunavir
drug prescriptions
legislation, drug
tablets
administration, oral
darunavir ethanolate
drug information

---
http://www.has-sante.fr/portail/jcms/c_882764/synthese-d-avis-prezista-ct-6572-6833
http://www.has-sante.fr/portail/jcms/c_816312/prezista-ct-6572-6833
http://www.has-sante.fr/portail/jcms/c_882765/prezista-300-mg-et-600-mg-darunavir-inhibiteur-de-protease
2009
false
France
French
Darunavir
Darunavir
darunavir ethanolate
hiv infections
treatment outcome
hiv protease inhibitors
adult
HIV-1
administration, oral
darunavir
insurance, health, reimbursement
drug therapy, combination
hiv protease inhibitors
evaluation of the transparency committee
guidelines for drug use

---
http://www.meddispar.fr/index.php/medicaments/3931383
2009
false
France
French
Darunavir
darunavir ethanolate
darunavir
drug prescriptions
legislation, drug
tablets
administration, oral
drug information

---
http://www.has-sante.fr/portail/jcms/c_882760/synthese-d-avis-prezista-ct-6571
http://www.has-sante.fr/portail/jcms/c_813779/prezista-ct-6571
http://www.has-sante.fr/portail/jcms/c_882761/prezista-400-mg-darunavir-inhibiteur-de-protease
2009
false
France
French
Darunavir
darunavir ethanolate
hiv infections
hiv protease inhibitors
drug therapy, combination
darunavir
insurance, health, reimbursement
adult
HIV-1
evaluation of the transparency committee
guidelines for drug use

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14513a-fra.php
2008
false
Canada
French
English
Darunavir
darunavir ethanolate
Chemical and Drug Induced Liver Injury
hiv protease inhibitors
acute disease
liver diseases
drug monitoring
continuity of patient care
drug therapy, combination
adult
darunavir
pharmacovigilance note
patient education handout

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Prezista_Fr.pdf
2007
false
Canada
French
Darunavir
hiv infections
hiv protease inhibitors
darunavir ethanolate
darunavir
drug evaluation

---
Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.